Advertisement

Quality of Life in Hemophilia

  • S. V. Mackensen
  • A Gringeri
Reference work entry

Abstract:

Haemophilia is a congenital bleeding disorder affecting about 1 out of 10,000 people in the general population. Haemophilia is characterized by post-traumatic and spontaneous bleeds, mainly in joints and muscles. Treatment is based on replacement of lacking factors by intravenous infusions when bleeding occurs or preventively. HR-QOL assessment is increasingly recognised as an important health outcome measure in haemophilia, which can help to optimise the treatment and to understand which treatment strategy fits the patients’ needs best. HR-QOL instruments can be distinguished between generic vs. disease-specific measures and instruments for adults and for children. Although the modern management of haemophilia has improved over the last decades patients still can suffer from a burden of their disease regarding clinical (such as treatment complications, presence of inhibitors, pain and arthropathy), psychological (stress and coping, anxiety and depression, stigmatisation and discrimination) and economical aspects. For an adequate assessment of HR-QoL in haemophilic patients validated instruments are necessary. Only in the last 6 years disease-specific HR-QoL instruments have been developed for haemophilic children, namely the European Haemo-QoL, the Canadian CHO-KLAT, the American Quality of Life Questionnaire for Young Patients and for adult patients: the Medtap questionnaire (USA, Canada, Spain and Germany), the South American Hemolatin-QoL, the Italian Haem-A-QoL and the Spanish Hemofilia-QoL. Since treatment of haemophilia can impact on patients’ HR-QoL the assessment of treatment satisfaction becomes quite important providing information for clinical trials and disease management programs. The first haemophilia-specific treatment satisfaction questionnaire for haemophilia patients is described (Hemo-SatA). Development and psychometric testing of these questionnaires is described in detail and revealed that all instruments are reliable and valid instruments which can be used in clinical trials. The choice of an instrument should be based on study-related and instrument-related issues. Results of HR-QoL studies are described concerning treatment effects, severity of the disease, complications and side effects and comparison with the general population.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Primary Prophylaxis Physical Component Summary Score Psychometric Characteristic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

CHQ

Child Health Questionnaire

GHQ

General Question of the Child Health Questionnaire

Hem-A-QOL

Hemophilia-specific quality of life instrument for adults

Hemo-QOL

Hemophilia-specific quality of life instrument for children and parents

Hemofilia-QOL

Hemophilia-specific quality of life instrument for adults

Hemolatin-QOL

Hemophilia-specific quality of life instrument for adults

Hemo-SatA

Hemophilia-specific treatment satisfaction questionnaire for adults and parents

HIV

Human Immune Deficiency Virus

HRQOL

 Health-Related Quality of Life

KINDL

Generic quality of life questionnaire for children

MCS

Mental Component Summary Score of the SF-36

Medtap

Hemophilia-specific quality of life instrument for adults

PCS

Physical Component Summary Score of the SF-36

PedsQL

Generic quality of life questionnaire for children

QOL

Quality of life

SF-36

Generic Quality of Life questionnaire for adults (Short-form 36)

TS

Treatment Satisfaction

References

  1. Aledort L, Haschmeyer R, Pettersson H. (1994). J Intern Med. 236: 391–339.PubMedGoogle Scholar
  2. Aledort LM. (2000). Haemostasis. 30(6): 333–336.PubMedGoogle Scholar
  3. Arranz P, Remor E, Quintana M, Villar A, Diaz JL, Moreno M, Monteagudo J, Ugarriza A, Soto I, Perez R, Chacon J, Garcia-Luaces M, Cid A, Balda I, Lopez MF, Gutierrez MJ, Martinez E, Marrero C, Prieto M, Sedano C, Vaca R, Altisent C, Hernandez-Navarro F, Hemofilia-QOL Group. (2004). Hemophilia. 10: 376–382.Google Scholar
  4. Aznar J, Magall M, Querol F, Gorina E, Tusell J. (2000). Hemophilia. 6: 170–176.Google Scholar
  5. Barlow JH, Stapley J, Ellard DR. (2007) Patient Educ Couns. 68(3): 235–242.PubMedGoogle Scholar
  6. Barrowcliffe TW. (2004). Hemophilia. 10(Suppl 4): 109–114.Google Scholar
  7. Barr RD, Saleh M, Furlong W, Horsman J, Sek J, Pai M, Walker I. (2002). Am J Hematol. 71(3): 152–160.PubMedGoogle Scholar
  8. Beeton K, Neal D, Watson T, Lee CA. (2007). Hemophilia. 13(5): 570–579.Google Scholar
  9. Berntorp E. (1995). Hemophilia 1(Suppl. 1): 3–7.Google Scholar
  10. Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. (2003). Hemophilia 9(Suppl 1): 1–4.Google Scholar
  11. Berntorp E, Boulyjenkov V, Brettler D, Chandy M, Jones P, Lee C, Lusher J, Mannucci P, Peak I, Rickard K, et al. (1995). Bull World Health Organ. 73(5): 691–701.PubMedGoogle Scholar
  12. Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CR, Hoots WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. (2006). Hemophilia. 12(Suppl 6): 1–7.Google Scholar
  13. Björkman S. (2003). Hemophilia. 9(Suppl 1): 101–8.Google Scholar
  14. Bolton-Maggs PH. (2006). Br J Haematol. 132(6): 671–682.PubMedGoogle Scholar
  15. Bottos AM, Zanon E, Sartori MT, Girolami A. (2007). Hemophilia. 13(3): 305–310.Google Scholar
  16. Bowling A. (1991). “Measuring Health. A Review of Quality of Life Measurement Scales”, Milton Keynes. Open University Press: Philadelphia.Google Scholar
  17. Bowling A. (2001). “Measuring disease. A review of disease-specific quality of life measurement scales”, Open University Press, Buckingham.Google Scholar
  18. Brown P. (2007). Hemophilia. 13(Suppl 5): 33–40.Google Scholar
  19. Bullinger M. (1991). Thero Surg. 6: 143–149.Google Scholar
  20. Bullinger M, Mackensen S, The Haemo-QOL Group. (2003). J Pediatr Haematol Oncol. 25(Suppl. 1): 64–67.Google Scholar
  21. Bullinger M, von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U, Roccino A, Sagnier P, Tusell J, van den Berg M, Vicariot M. (2002). Hemophilia. 8(Suppl. 2): 47–54.Google Scholar
  22. Bussing R, Burket RC. (1993). J Am Acad Child Adolesc Psychiatry. 32(3): 562–567.PubMedGoogle Scholar
  23. Canclini M, Saviolo-Negrin N, Zanon E, Bertoletti R, Girolami A, Pagnan A. (2003). Hemophilia. 9(5): 619–624.Google Scholar
  24. Cella DF, Tulsky DS. (1993). Oncology. 29–38.Google Scholar
  25. Centers of Disease Control. (1982). “Update on Acquired Immune Deficiency Syndrome (AIDS) Among Patients with Hemophilia”, MMWR Wkly. 31: 644–652.Google Scholar
  26. Choo KH, Gould KG, Rees DJG, Brownlee GG. (1982). Nature. 299: 178–80.PubMedGoogle Scholar
  27. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M. (2007). Blood. 110(3): 815–25.PubMedGoogle Scholar
  28. Donadel-Claeyssens S. On behalf of the European Paediatric Network for Hemophilia Management. (2006). Hemophilia. 12: 124–127.Google Scholar
  29. Drotar D, Agle DP, Eckl CL, Thompson PA. (1997). J Pediatr Psychol. 22(1): 1–14.PubMedGoogle Scholar
  30. Ehrlich HJ, Henzl MJ, Gomperts ED. (2002). Hemophilia. 8: 83–90.Google Scholar
  31. Eiser C, Morse R. (2001). Arch Dis Child. 84: 205–211.PubMedGoogle Scholar
  32. Evatt BL. (2005). Semin Thromb Hemost. 31(5): 489–494.PubMedGoogle Scholar
  33. Ewenstein BM, Valentino LA, Journeycake JM, Tarantino MD, Shapiro AD, Blanchette VS, Hoots WK, Buchanan GR, Manco-Johnson MJ, Rivard GE, Miller KL, Geraghty S, Maahs JA, Stuart R, Dunham T, Navickis RJ. (2004). Hemophilia. 10(5): 629–48.Google Scholar
  34. Fischer K, Astermark J, van der Bom J, Ljung R, Berntorp E, Grobbees D, van den Berg HM. (2002). Hemophilia. 8: 753–760.Google Scholar
  35. Flood E, Szende A, Rentz A, Gorina E, Larson P, Bullinger M, Schramm W, Wasserman J, Leidy NK. (2003). Journal of Thrombosis and Haemostasis. 1(suppl. 1): abstract number P0657.Google Scholar
  36. Freiburghaus C, Berntorp E, Ekman M, Gunnarsson J, Kjellberg BM, Nilsson IM. (2002). Hemophilia. 4: 16–20.Google Scholar
  37. Furie B, Limentani SA, Rosenfield CG. (1994). Blood. 84: 3–9.PubMedGoogle Scholar
  38. Giangrande PL. (2003). Hemophilia. 9(Suppl 1): 50–4.Google Scholar
  39. Giannelli F, Green PM. (1996). Bailliere’s Hematol. 9: 211–228.Google Scholar
  40. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM. (1984). Nature. 312: 326–30.PubMedGoogle Scholar
  41. Gringeri A, Mannucci PM. Italian Association of Hemophilia Centres. (2005). Hemophilia. 11(6): 611–619.Google Scholar
  42. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. (2003). Blood. 102: 2358–2363.PubMedGoogle Scholar
  43. Gringeri A, Mantovani L, von Mackensen S. (2006). Hemophilia: 12(Suppl. 3): 22–29.Google Scholar
  44. Gringeri A, von Mackensen S. (2008). Hemophilia. 14(Suppl 3): 19–25.Google Scholar
  45. Gringeri A, von Mackensen S, Auerswald G, Bullinger M, Perez Garrido R, Kellermann E, Khair K, Lenk H, Vicariot M, Villar A, Wermes C. For the Haemo-QOL Study. (2004). Hemophilia. 1, 10(Suppl. 1): 26–33.Google Scholar
  46. Hartl HK, Reitter S, Eidher U, Ramschak H, Ay C, Pabinger I. (2008). Hemophilia. 1: 1–6.Google Scholar
  47. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. (2006). Br J Haematol. 133(6): 591–605.PubMedGoogle Scholar
  48. Hay C, Recht M, Carcao M, Reipert B. (2006). Semin Thromb Hemost. 32(Suppl 2): 15–21.PubMedGoogle Scholar
  49. Hilgartner M, Knatterud GL, The FEIBA Study Group. (1983). Blood. 61: 36–40.PubMedGoogle Scholar
  50. Holahan CJ, Moos RH. (1987). J Abnorm Psychol. 96: 3–13.PubMedGoogle Scholar
  51. Jadhav M, Warrier I. (2000). Semin Thromb Hemost. 26(2): 205–8.PubMedGoogle Scholar
  52. Jones QJ, Garsia RJ, Wu RT, Job RF, Dunn SM. (1995). J Psychosom Res. 39(5): 597–608.PubMedGoogle Scholar
  53. Karimi M, Peyvandi F, Siboni S, Ardeshirim R, Gringeri A, Mannucci PM. (2004). Hemophilia. 10(4): 367–369.Google Scholar
  54. Key NS, Negrier C. (2007). Lancet. 370(9585): 439–48.PubMedGoogle Scholar
  55. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Körholz C, Kreuz W. (1999). Eur J Pediatr. 158: 162–5.Google Scholar
  56. Komvilaisak P, Connolly B, Naqvi A, Blanchette V. (2006). Hemophilia. 12(Suppl 6): 87–93.Google Scholar
  57. Kraus EM, Brettler DB. (1988). Am J Med Genet. 31(2): 259–267.PubMedGoogle Scholar
  58. Lacey L. (2002). Pathophysiol Haemost Thromb 32:(suppl 1):29–32.PubMedGoogle Scholar
  59. Liesner RJ, Khair K, Hann IM. (1996). Br J Haematol. 92: 973–978.PubMedGoogle Scholar
  60. Ljung R. (2007). Br J Haematol. 138(5): 580–586.PubMedGoogle Scholar
  61. Ljung R, Petrini P, Nilsson IM. (1990). Acta Paediatr Scand. 79: 196–200.PubMedGoogle Scholar
  62. Lloyd Jones M, Wight J, Paisley S, Knight C. (2003). Hemophilia. 9: 464–520.Google Scholar
  63. Lusher J, Ingerslev J, Roberts H, Hedner U. (1998). Blood Coagul Fibrinolysis. 9: 119–28.PubMedGoogle Scholar
  64. Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè MC, Vassilief D, Lopez I, Goudemand J, Negrier C, Assogba U, Driss F, Dumont MA, Molho P. (2004). Hemophilia. 10(5): 572–581.Google Scholar
  65. Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. (2004). Hemophilia. 10: 34–41.Google Scholar
  66. Mann KG. (1999). Thromb Haemost. 278: 9370–7.Google Scholar
  67. Mannucci PM. (2003). J Thromb Haemos. 1: 1349–1355.Google Scholar
  68. Miller R, Sabin C, Goldman E, Clemente C, Sadowski H, Lee CA. (2000). Psychol Health Med. 5: 3–12.Google Scholar
  69. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. (1999). Hemophilia. 5(6): 378–85.Google Scholar
  70. Molho P, Rolland N, Lebrun T, Dirat G, Courpied J, Croughs T, Duprat I, Sultan Y. (2000). Hemophilia. 6: 23–32.Google Scholar
  71. Monat A, Lazarus RS. (1977). “Stress and Coping: An Anthology”, Columbia University Press, New York, pp.6.Google Scholar
  72. Morfini M. (2003). Hemophilia. 9(Suppl 1): 94–9.Google Scholar
  73. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. The members of the French FEIBA study group. (1997). Thromb Haemost. 77: 1113–1119.PubMedGoogle Scholar
  74. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. (1992). J Intern Med 232(1): 25–32.PubMedGoogle Scholar
  75. Pollak E, Mühlan H, von Mackensen S, Bullinger M. the Haemo-QOL Group. (2006). Hemophilia. 12: 384–392.Google Scholar
  76. “Prevention and Control of Hemophilia: Memorandum from a Joint WHO/WFH Meeting”. (1991). Bull World Health Organ. LXIX. 1: 17–26.Google Scholar
  77. Prowse C, Ludlam CA, Yap PL. (1997). Vox Sang. 72(1): 1–10.PubMedGoogle Scholar
  78. Remor E. (2005). Revista Interamericana de Psicología/ Interamerican J Psychol. 39(2), 211–220.Google Scholar
  79. Remor E, Arranz P, Quintana M, Villar A, Jimenez-Yuste V, Diaz JL, Del Rincon C, Marrero C, Moreno M, Lucia JF, Martinez E, Soto I, Sedano C, Gonzalez-Boullosa R, Prieto M, Garcia-Luaces M, Hernandez-Navarro F, in representation of the Hemofilia-QOL Project Group. (2005). Hemophilia. 11: 603–610.Google Scholar
  80. Remor E, Young NL, von Mackensen S, Lopatina EG. (2004). Hemophilia. 10(Suppl. 4): 30–34.Google Scholar
  81. Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP, Scharrer I, Schramm W, Gorina E. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008; 14(5): 1023–1034.Google Scholar
  82. Report of a Joint WHO/WFH/ISTH Meeting. (2002). “Delivery of Treatment for Hemophilia”, World Health Organization. London, UK.Google Scholar
  83. Rizza CR. (1984). Scand J Haematol. 40(Suppl.33): 187–193.Google Scholar
  84. Roberts HR, Monroe DM. 3rd, Hoffman M. (2004). Semin Hematol. 41(suppl 1): 101–108.PubMedGoogle Scholar
  85. Rosendaal FR, Smit C, Varekamp I, Bröcker-Vriends AH, van Dijck H, Suurmeijer TP, Vandenbroucke JP, Briët E. (1990). J Intern Med. 228: 663–640.Google Scholar
  86. Rosendaal G, van der Berg HM, Lafeber FPJG, Bijlsma JWJ. (2000). “Blood-induced joint damage: an overview of musculoskeletal research in hemophilia”, In: Rodriguez-Merchan EC, Goddard NJ, Lee CA (eds.) “Muskuloskeletal Aspects of Hemophilia”, Blackwell Science Ltd, Oxford, UK, pp. 18–26.Google Scholar
  87. Rotter JB. (1954). “Social Learning and Clinical Psychology”. Prentice-Hall.New YorkGoogle Scholar
  88. Royal S, Schramm W, Berntorp E, Giangrande P, Gringeri, A, Ludlam C, Kroner B, Szucs T, for the European hemophilia economics study group. (2002). Hemophilia. 8: 44–50.Google Scholar
  89. Santagostino E, Gringeri A, Berardinelli L, Beretta C, Muça-Perja M, Mannucci PM. (2003). Br J Haematol. 123(3): 502–506.PubMedGoogle Scholar
  90. Santagostino E, Gringeri A, Mannucci PM. (1999). Br J Haematol. 104: 22–26.PubMedGoogle Scholar
  91. Saviolo-Negrin N, Cristante F, Zanon E, Canclini M, Stocco D, Girolami A. (1999). Hemophilia 5(1): 63–68.Google Scholar
  92. Schick M, Stucki G, Rodriguez M, Meili E, Huber E, Michel B, Bruhlmann P. (1999). Clin-Rheumatol. 18: 468–472.PubMedGoogle Scholar
  93. Schoenmakers M, Gulmans V, Helders P, van den Berg HM. (2001). Hemophilia. 7: 293–298.Google Scholar
  94. Schramm W, Royal S, Kroner B, Berntorp E, Giangrande P, Ludlam C, Gringeri A, Berger K, Szucs T. For the European hemophilia economic study group. (2002). “Clinical outcomes and resource utilization associated with hemophilia care in Europe”, Hemophilia. 8: 33–43.Google Scholar
  95. Shapiro A, Donfield S, Lynn H, Cool V, Stehbens J, Hunsberger S, Tonetta S, Gomperts E.D. Academic Achievement in Children with Hemophilia Study Group. (2001). Pediatrics. 108: 6:e105.PubMedGoogle Scholar
  96. Solovieva S. (2001). Hemophilia. 7: 53–63.Google Scholar
  97. Spielberger CD. (1972). “Anxiety: Current trends in theory and research”, Academic Press. New York, N.Y.Google Scholar
  98. Sung L, Young NL, Greenberg ML, McLimont M, Samanta T, Wong J, Rubenstein J, Ingber S, Doyle JJ, Feldman BM. (2004). J Clin Epidemiol. 57(11): 1161–1166.PubMedGoogle Scholar
  99. Szucs TD, Offner A, Schramm W. (1996). Hemophilia. 2: 211–217.Google Scholar
  100. Tedgård U, Ljung R, McNeil TF. (1999). Br J Haematol. 106(2): 421–426.PubMedGoogle Scholar
  101. Teitel J, Berntorp E, Collins P, D’Oiron R, Ewenstein B, Gomperts E, Goudemand J, Gringeri A, Key N, Leissinger C, Monahan P,Young G. (2007). Hemophilia. 13(3): 256–63.Google Scholar
  102. The WHOQOL Group. Study protocol for the World Health Organization. Project to develop a Quality of Life assessment instrument (WHOQOL) (1993). Qual Life Res. 2: 153–159.Google Scholar
  103. Triemstra AH, Van der Ploeg HM, Smit C, Briët E, Adèr HJ, Rosendaal FR. (1998). Soc Sci Med. 47(5): 581–593.PubMedGoogle Scholar
  104. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. (2001). Haematologica. 86: 722–728.PubMedGoogle Scholar
  105. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Gomperts E, Buchanan G. (1993). Blood. 81: 412–418.PubMedGoogle Scholar
  106. Vermilen J, Peerlink K. (1994). Vox Sang. 84 (Suppl 4): 8–11.Google Scholar
  107. von Mackensen S. (2007). Hemophilia. 13(2): 38–43.Google Scholar
  108. von Mackensen S, Bullinger M, The Haemo-QOL Group. (2004). Hemophilia. 10(Suppl. 1): 17–25.Google Scholar
  109. von Mackensen SV., Gringeri A. (2005). “Quality of Life in Hemophilia”. In: Lee CA, Berntorp EE, Keith Hoots W. (eds.) Textbook of Hemophilia. Blackwell Publishing Ltd. Oxford, UK, pp. 345–350.Google Scholar
  110. von Mackensen S, Gringeri A, Mantovani L, Skovlund SE, Mannucci PM. (2002). Blood. 100(11) (Abstract).Google Scholar
  111. von Mackensen S, Gringeri A, Mantovani L, Skovlund S, Santoni L, Tagliaferro A, Tagariello G, Ciavarella N, Iorio A. (2004). Hemophilia. 10(Suppl. 3): 126 (Abstract).Google Scholar
  112. von Mackensen S, Gringeri A, Ravera S, (2005). the Haem-A-QOL Group. Haematologica. 90(Suppl. 2): 116–117 [Abstract 0290].Google Scholar
  113. von Mackensen S, Gringeri A, Santoni L, Tagliaferro A, Tagariello G, Ciavarella N, Iorio A, Molinari C. (2004). Blood. 104(11): 2214 [Abstract].Google Scholar
  114. von Mackensen S, Gringeri A, Scalone L, Mantovani L, (2005). the COCHE Study Group. Haematologica. 90(Suppl 2): 310. [Abstract 0778].Google Scholar
  115. von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A. For the COCHE Study Group. (2007). “Quality of Life Assessment in Adult Patients with Hemophilia – Results of the COCHE Study”, Oral presentation at the annual congress of the Society of Thrombosis and Haemostasis Research. Dresden, 21–25 February 2007, FV19.Google Scholar
  116. von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A, (2005). for the COCHE Study Group. Value Health 8(6): A127 [Abstract PHM5].Google Scholar
  117. von Mackensen S, Siboni SM, Gringeri A, Tradati F, Franchini M, Tagliaferro A, Mannucci PM. (2008). Hemophilia. 14(s2): 127 [Abstract 22 S 01].Google Scholar
  118. Walsh M, Macgregor D, Stuckless S, Barrett B, Kawaja M, Scully MF. (2008). J Thromb Haemost 6(5): 755–761.PubMedGoogle Scholar
  119. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. (1997). A J Manag Care. 3: 579–594.Google Scholar
  120. White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. (2001). Thromb Haemost 85: 560.PubMedGoogle Scholar
  121. Wiener LS, Vasquez MJ, Battles HB. (2001).J Pediatr Psychol. 26(6): 353–358.PubMedGoogle Scholar
  122. Wight J, Paisley S. (2003). Hemophilia 9(4): 418–35.Google Scholar
  123. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. (2005). Qual Life Res 14(2): 285–295.PubMedGoogle Scholar
  124. Yi M, Kim WO, Kang HS. (2003) Taehan Kanho Hakhoe Chi. 33:(7)875–884.PubMedGoogle Scholar
  125. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. (2006). Pediatr Blood Cancer. 47: 305–311.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • S. V. Mackensen
    • 1
  • A Gringeri
    • 2
  1. 1.Institute and Policlinics of Medical PsychologyUniversity Medical Centre Hamburg-EppendorfMartinistrGermany
  2. 2.Angelo Bianchi Bonomi Hemophilia and Thrombosis CentreIRCCS Maggiore Hospital and University of MilanMilanItaly

Personalised recommendations